We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Considers Using Big Data and Real-World Evidence in Approval Decisions
EMA Considers Using Big Data and Real-World Evidence in Approval Decisions
The EMA identified ways to address the drawbacks of using electronic healthcare records and real-world evidence to support drug development and regulatory decision-making.